These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 22882459)

  • 1. Overview of pharmacoeconomic modelling methods.
    Ademi Z; Kim H; Zomer E; Reid CM; Hollingsworth B; Liew D
    Br J Clin Pharmacol; 2013 Apr; 75(4):944-50. PubMed ID: 22882459
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Use of pharmacoeconomics in prescribing research. Part 5: modelling--beyond clinical trials.
    Lang DL; Lopert R; Hill SR
    J Clin Pharm Ther; 2003 Oct; 28(5):433-9. PubMed ID: 14632969
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation and review of pharmacoeconomic models.
    Hay JW
    Expert Opin Pharmacother; 2004 Sep; 5(9):1867-80. PubMed ID: 15330725
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interest of modelling in rheumatoid arthritis.
    Beresniak A; Dupont DM; Becker JC; Merkesdal S
    Clin Exp Rheumatol; 2012; 30(4 Suppl 73):S96-101. PubMed ID: 23078913
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Decision-analytical modelling in health-care economic evaluations.
    Sun X; Faunce T
    Eur J Health Econ; 2008 Nov; 9(4):313-23. PubMed ID: 17943332
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Methods for analyzing uncertainty].
    Ferriols R; Alós M
    Farm Hosp; 2011 May; 35 Suppl 2():3-9. PubMed ID: 22445503
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An introduction to the methods of decision-analytic modelling used in economic evaluations for Dermatologists.
    McManus E; Sach TH; Levell NJ
    J Eur Acad Dermatol Venereol; 2019 Oct; 33(10):1829-1836. PubMed ID: 31127965
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An introduction to Markov modelling for economic evaluation.
    Briggs A; Sculpher M
    Pharmacoeconomics; 1998 Apr; 13(4):397-409. PubMed ID: 10178664
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacoeconomics and formulary decision making.
    Sanchez LA
    Pharmacoeconomics; 1996; 9 Suppl 1():16-25. PubMed ID: 10160112
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Handling input correlations in pharmacoeconomic models.
    Naveršnik K; Rojnik K
    Value Health; 2012 May; 15(3):540-9. PubMed ID: 22583465
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rank-order stability analysis (ROSA): testing pharmacoeconomic data.
    Einarson TR; Arikian SR; Doyle JJ
    Med Decis Making; 1995; 15(4):367-72. PubMed ID: 8544680
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Incorporation of statistical uncertainty in health economic modelling studies using second-order Monte Carlo simulations.
    Nuijten MJ
    Pharmacoeconomics; 2004; 22(12):759-69. PubMed ID: 15294010
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Introduction to Cost Analysis in IR: Challenges and Opportunities.
    Roudsari B; McWilliams J; Bresnahan B; Padia SA
    J Vasc Interv Radiol; 2016 Apr; 27(4):539-545.e1. PubMed ID: 26922978
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Health economic models: a question of balance--summary of an open discussion on the pharmacoeconomic evaluation of non-steroidal anti-inflammatory drugs.
    Drummond MF
    Rheumatology (Oxford); 2000 Dec; 39 Suppl 2():29-32. PubMed ID: 11276799
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Decision analysis and economic modelling: a primer.
    Inadomi JM
    Eur J Gastroenterol Hepatol; 2004 Jun; 16(6):535-42. PubMed ID: 15167154
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacoeconomics: state of the art in 1997.
    Schulman KA; Linas BP
    Annu Rev Public Health; 1997; 18():529-48. PubMed ID: 9143730
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Penny and pound wise: pharmacoeconomics from a governmental perspective.
    van Oostenbruggen MF; Jansen RB; Mur K; Kooijman H
    Pharmacoeconomics; 2005; 23(3):219-26. PubMed ID: 15836004
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Principles of pharmacoeconomic analysis of drug therapy.
    Freund DA; Dittus RS
    Pharmacoeconomics; 1992 Jan; 1(1):20-31. PubMed ID: 10147037
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Disease modelling in diabetes mellitus].
    Schramm W; Schöffski O; Görtz A; Liebl A
    Dtsch Med Wochenschr; 2004 Oct; 129(43):2305-10. PubMed ID: 15483770
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The rationale of pharmacoeconomic analysis in rheumatologic indications.
    Turchetti G; Scalone L; Della Casa Alberighi O; Mosca M; Montella S; Cortesi PA; Mantovani LG
    Clin Exp Rheumatol; 2012; 30(4 Suppl 73):S64-71. PubMed ID: 23072796
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.